SCHEMBL4698725

SCHEMBL4698725

O=C1C(Cc2ccc3ccc(-c4ccccc4O)cc3c2)CCN1C1CCCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.57
ESR2 Q92731 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
CYP26A1 O43174 1/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CCR5 P51681 2/20 0.33
HDAC4 P56524 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
OPRM1 P35372 2/20 0.32
OPRL1 P41146 2/20 0.32
CASR P41180 1/20 0.32
CES2 O00748 1/20 0.32
CDK1 P06493 1/20 0.32
CCNE1 P24864 1/20 0.32
CDK2 P24941 1/20 0.32
KDM2B Q8NHM5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4697453 0.84 HSD11B1 (0.57) HSD11B1ALDH1A1MCOLN3KDM4EMAPT
SCHEMBL4510178 0.84 HSD11B1 (0.71) HSD11B1ALDH1A1MCOLN3OPRM1OPRL1
SCHEMBL4696769 0.83 HSD11B1 (0.60) HSD11B1ESR2ALDH1A1MCOLN3CYP26A1
SCHEMBL4698597 0.81 HSD11B1 (0.53) HSD11B1ALDH1A1MCOLN3
SCHEMBL4697040 0.81 HSD11B1 (0.55) HSD11B1ALDH1A1L3MBTL1CCR5KDM2B
SCHEMBL4697530 0.80 HSD11B1 (0.61) HSD11B1ESR2ALDH1A1MCOLN3CYP26A1
SCHEMBL4697482 0.80 HSD11B1 (0.61) HSD11B1ALDH1A1MCOLN3KDM4EMAPT
SCHEMBL4699865 0.78 HSD11B1 (0.62) HSD11B1ALDH1A1MCOLN3OPRM1OPRL1
SCHEMBL4700534 0.78 HSD11B1 (0.48) HSD11B1ALDH1A1KDM4EL3MBTL1OPRL1
SCHEMBL4701145 0.78 HSD11B1 (0.51) HSD11B1ALDH1A1MCOLN3CASRCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-09-04 US claimed
EP-1830841-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2008-07-02 EP claimed
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-09-04 US disclosed
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-09-04 US disclosed
EP-1830841-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2008-07-02 EP disclosed
EP-1830841-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSD17B1, HSD3B1 HSD11B1 1/4885ESR2 1940/4885ALDH1A1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.